Sirtuins as emerging anti-parasitic targets

European Journal of Medicinal Chemistry

Volumn 59, Issue , 2013, Pages 132-140

  Zheng, Weiping ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Disease; Inhibitor; Parasite; Protein deacetylase; Sirtuin; Therapy

Indexed keywords

ERYTHROCYTE MEMBRANE PROTEIN 1; SIRTUIN;

ANTIGENIC VARIATION; ANTIMICROBIAL THERAPY; ARTICLE; BINDING SITE; CATALYSIS; CHEMICAL ANALYSIS; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM PARVUM; ENZYME ANALYSIS; ENZYME STRUCTURE; HUMAN; IMMUNOSURVEILLANCE; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MOLECULARLY TARGETED THERAPY; NONHUMAN; PARASITE SURVIVAL; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PROTEIN FUNCTION; STRUCTURE ANALYSIS; TOXOPLASMA GONDII; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI;

EID: 84870374892     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.11.014     Document Type: Review

References (112)

1. T. Kouzarides Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19 2000 1176 1179
2. S.L. Schreiber, and B.E. Bernstein Signaling network model of chromatin Cell 111 2002 771 778
3. M.A. Glozak, N. Sengupta, X. Zhang, and E. Seto Acetylation and deacetylation of non-histone proteins Gene 363 2005 15 23
4. S.C. Hodawadekar, and R. Marmorstein Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design Oncogene 26 2007 5528 5540
5. K. Batta, C. Das, S. Gadad, J. Shandilya, and T.K. Kundu Reversible acetylation of non histone proteins: role in cellular function and disease Subcell. Biochem. 41 2007 193 212
6. M.D. Shahbazian, and M. Grunstein Functions of site-specific histone acetylation and deacetylation Annu. Rev. Biochem. 76 2007 75 100
7. M. Arif, B.R. Selvi, and T.K. Kundu Lysine acetylation: the tale of a modification from transcription regulation to metabolism ChemBioChem 11 2010 1501 1504
8. M. Arif, P. Senapati, J. Shandilya, and T.K. Kundu Protein lysine acetylation in cellular function and its role in cancer manifestation Biochim. Biophys. Acta 1799 2010 702 716
9. J.A. Aka, G.W. Kim, and X.J. Yang K-Acetylation and its enzymes: overview and new developments Handb. Exp. Pharmacol. 206 2011 1 12
10. G.W. Kim, and X.J. Yang Comprehensive lysine acetylomes emerging from bacteria to humans Trends Biochem. Sci. 36 2011 211 220
11. T.-P. Yao, and E. Seto Histone Deacetylases: The Biology and Clinical Implication (Handbook of Experimental Pharmacology) 2011 Springer
12. E. Verdin Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions (Cancer Drug Discovery and Development 2010 Humana Press
13. X.J. Yang, and E. Seto HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention Oncogene 26 2007 5310 5318
14. L.R. Saunders, and E. Verdin Sirtuins: critical regulators at the crossroads between cancer and aging Oncogene 26 2007 5489 5504
15. T. Zhang, and W.L. Kraus SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions Biochim. Biophys. Acta 1804 2010 1666 1675
16. T. Finkel, C.X. Deng, and R. Mostoslavsky Recent progress in the biology and physiology of sirtuins Nature 460 2009 587 591
17. S. Imai, and L. Guarente Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases Trends Pharmacol. Sci. 31 2010 212 220
18. M.C. Haigis, and D.A. Sinclair Mammalian sirtuins: biological insights and disease relevance Annu. Rev. Pathol. 5 2010 253 295
19. J.R. Knight, and J. Milner SIRT1, metabolism and cancer Curr. Opin. Oncol. 24 2012 68 75
20. K.L. Guan, and Y. Xiong Regulation of intermediary metabolism by protein acetylation Trends Biochem. Sci. 36 2011 108 116
21. M.D. Hirschey, T. Shimazu, J.Y. Huang, B. Schwer, and E. Verdin SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism Cold Spring Harb. Symp. Quant. Biol. 76 2011 267 277
22. L. Guarente Sirtuins, aging, and metabolism Cold Spring Harb. Symp. Quant. Biol. 76 2011 81 90
23. K.A. Anderson, and M.D. Hirschey Mitochondrial protein acetylation regulates metabolism Essays Biochem. 52 2012 23 35
24. R.H. Houtkooper, E. Pirinen, and J. Auwerx Sirtuins as regulators of metabolism and healthspan Nat. Rev. Mol. Cell. Biol. 13 2012 225 238
25. B. Martinez-Pastor, and R. Mostoslavsky Sirtuins, metabolism, and cancer Front. Pharmacol. 3 2012 Article 22
26. A. Chalkiadaki, and L. Guarente Sirtuins mediate mammalian metabolic responses to nutrient availability Nat. Rev. Endocrinol. 8 2012 287 296
27. S. Mujtaba, L. Zeng, and M.M. Zhou Structure and acetyl-lysine recognition of the bromodomain Oncogene 26 2007 5521 5527
28. R. Sanchez, and M.M. Zhou The role of human bromodomains in chromatin biology and gene transcription Curr. Opin. Drug Discov. Dev. 12 2009 659 665
29. S.Y. Roth, J.M. Denu, and C.D. Allis Histone acetyltransferases Annu. Rev. Biochem. 70 2001 81 120
30. R. Marmorstein, and S.Y. Roth Histone acetyltransferases: function, structure, and catalysis Curr. Opin. Genet. Dev. 11 2001 155 161
31. X.J. Yang The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases Nucleic Acids Res. 32 2004 959 976
32. G. Blander, and L. Guarente The Sir2 family of protein deacetylases Annu. Rev. Biochem. 73 2004 417 435
33. J.M. Denu The Sir2 family of protein deacetylases Curr. Opin. Chem. Biol. 9 2005 431 440
34. A.A. Sauve, C. Wolberger, V.L. Schramm, and J.D. Boeke The biochemistry of sirtuins Annu. Rev. Biochem. 75 2006 435 465
35. C.E. Berndsen, and J.M. Denu Catalysis and substrate selection by histone/protein lysine acetyltransferases Curr. Opin. Struct. Biol. 18 2008 682 689
36. X.J. Yang, and E. Seto The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men Nat. Rev. Mol. Cell. Biol. 9 2008 206 218
37. J.Y. Huang, M.D. Hirschey, T. Shimazu, L. Ho, and E. Verdin Mitochondrial sirtuins Biochim. Biophys. Acta 1804 2010 1645 1651
38. Y. Cen, D.Y. Youn, and A.A. Sauve Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications Curr. Med. Chem. 18 2011 1919 1935
39. ε-acetyl-lysine analogs Mol. Biosyst. 7 2011 16 28
40. +-dependent deacetylation reactions Biochemistry 40 2001 15456 15463
41. R.A. Frye Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins Biochem. Biophys. Res. Commun. 273 2000 793 798
42. S. Thiagalingam, K.H. Cheng, H.J. Lee, N. Mineva, A. Thiagalingam, and J.F. Ponte Histone deacetylases: unique players in shaping the epigenetic histone code Ann. N. Y. Acad. Sci. 983 2003 84 100
43. I.V. Gregoretti, Y.M. Lee, and H.V. Goodson Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis J. Mol. Biol. 338 2004 17 31
44. S. Greiss, and A. Gartner Sirtuin/Sir2 phylogeny, evolutionary considerations and structural conservation Mol. Cells 28 2009 407 415
45. J. Gu, J.Y. Deng, R. Li, H. Wei, Z. Zhang, Y. Zhou, Y. Zhang, and X.E. Zhang Cloning and characterization of NAD-dependent protein deacetylase (Rv1151c) from Mycobacterium tuberculosis Biochemistry (Mosc) 74 2009 743 748
46. A.C. Tucker, and J.C. Escalante-Semerena Biologically active isoforms of CobB sirtuin deacetylase in Salmonella enterica and Erwinia amylovora J. Bacteriol. 192 2010 6200 6208
47. Z. Li, J. Wen, Y. Lin, S. Wang, P. Xue, Z. Zhang, Y. Zhou, X. Wang, L. Sui, L.J. Bi, and X.E. Zhang A Sir2-like protein participates in mycobacterial NHEJ PLoS One 6 2011 e20045
48. J.A. García-Salcedo, P. Gijón, D.P. Nolan, P. Tebabi, and E. Pays A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei EMBO J. 22 2003 5851 5862
49. L. Figueiredo, and A. Scherf Plasmodium telomeres and telomerase: the usual actors in an unusual scenario Chromosome Res. 13 2005 517 524
50. D. Sereno, B. Vergnes, F. Mathieu-Daude, A. Cordeiro da Silva, and A. Ouaissi Looking for putative functions of the Leishmania cytosolic SIR2 deacetylase Parasitol. Res. 100 2006 1 9
51. S. Dam, and A. Lohia Entamoeba histolytica sirtuin EhSir2a deacetylates tubulin and regulates the number of microtubular assemblies during the cell cycle Cell. Microbiol. 12 2010 1002 1014
52. H. Yasukawa, and K. Yagita Silent information regulator 2 proteins encoded by Cryptosporidium parasites Parasitol. Res. 107 2010 707 712
53. +-dependent deacetylase Parasitology 138 2011 1245 1258
54. B. Yahiaoui, A. Taibi, and A. Ouaissi A Leishmania major protein with extensive homology to silent information regulator 2 of Saccharomyces cerevisiae Gene 169 1996 115 118
55. C.J. Tonkin, C.K. Carret, M.T. Duraisingh, T.S. Voss, S.A. Ralph, M. Hommel, M.F. Duffy, L.M. da Silva, A. Scherf, A. Ivens, T.P. Speed, J.G. Beeson, and A.F. Cowman Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum PLoS Biol. 7 2009 e1000084
56. S. Alsford, T. Kawahara, C. Isamah, and D. Horn A sirtuin in the African trypanosome is involved in both DNA repair and telomeric gene silencing but is not required for antigenic variation Mol. Microbiol. 63 2007 724 736
57. J. Pérez-Martín, J.A. Uría, and A.D. Johnson Phenotypic switching in Candida albicans is controlled by a SIR2 gene EMBO J. 18 1999 2580 2592
58. P. Trojer, E.M. Brandtner, G. Brosch, P. Loidl, J. Galehr, R. Linzmaier, H. Haas, K. Mair, M. Tribus, and S. Graessle Histone deacetylases in fungi: novel members, new facts Nucleic Acids Res. 31 2003 3971 3981
59. R. Domergue, I. Castaño, A. De Las Peñas, M. Zupancic, V. Lockatell, J.R. Hebel, D. Johnson, and B.P. Cormack Nicotinic acid limitation regulates silencing of Candida adhesins during UTI Science 308 2005 866 870
60. K.W. Deitsch Malaria virulence genes: controlling expression through chromatin modification Cell 121 2005 1 7
61. M.T. Duraisingh, T.S. Voss, A.J. Marty, M.F. Duffy, R.T. Good, J.K. Thompson, L.H. Freitas-Junior, A. Scherf, B.S. Crabb, and A.F. Cowman Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum Cell 121 2005 13 24
62. L.H. Freitas-Junior, R. Hernandez-Rivas, S.A. Ralph, D. Montiel-Condado, O.K. Ruvalcaba-Salazar, A.P. Rojas-Meza, L. Mâncio-Silva, R.J. Leal-Silvestre, A.M. Gontijo, S. Shorte, and A. Scherf Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites Cell 121 2005 25 36
63. B. Vergnes, D. Sereno, N. Madjidian-Sereno, J.L. Lemesre, and A. Ouaissi Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death Gene 296 2002 139 150
64. B. Vergnes, D. Sereno, J. Tavares, A. Cordeiro-da-Silva, L. Vanhille, N. Madjidian-Sereno, D. Depoix, A. Monte-Alegre, and A. Ouaissi Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation Gene 363 2005 85 96
65. C.J. Merrick, and M.T. Duraisingh Plasmodium falciparum Sir2: an unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity Eukaryot. Cell. 6 2007 2081 2091
66. M. Goyal, A. Alam, M.S. Iqbal, S. Dey, S. Bindu, C. Pal, A. Banerjee, S. Chakrabarti, and U. Bandyopadhyay Identification and molecular characterization of an Alba-family protein from human malaria parasite Plasmodium falciparum Nucleic Acids Res. 40 2012 1174 1190
67. +-dependent deacetylase and ADP-ribosyltransferase Biochem. J. 415 2008 377 386
68. T.M. Kowieski, S. Lee, and J.M. Denu Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2 J. Biol. Chem. 283 2008 5317 5326
69. A.A. Sauve Sirtuin chemical mechanisms Biochim. Biophys. Acta 1804 2010 1591 1603
70. K. Fahie, P. Hu, S. Swatkoski, R.J. Cotter, Y. Zhang, and C. Wolberger Side chain specificity of ADP-ribosylation by a sirtuin FEBS J. 276 2009 7159 7176
71. W.F. Hawse, and C. Wolberger Structure-based mechanism of ADP-ribosylation by sirtuins J. Biol. Chem. 284 2009 33654 33661
72. J. Du, H. Jiang, and H. Lin Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD Biochemistry 48 2009 2878 2890
73. + glycohydrolase Biochemistry 47 2008 10227 10239
74. M.C. Haigis, R. Mostoslavsky, K.M. Haigis, K. Fahie, D.C. Christodoulou, A.J. Murphy, D.M. Valenzuela, G.D. Yancopoulos, M. Karow, G. Blander, C. Wolberger, T.A. Prolla, R. Weindruch, F.W. Alt, and L. Guarente SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells Cell 126 2006 941 954
75. G. Liszt, E. Ford, M. Kurtev, and L. Guarente Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase J. Biol. Chem. 280 2005 21313 21320
76. Z. Mao, C. Hine, X. Tian, M. Van Meter, M. Au, A. Vaidya, A. Seluanov, and V. Gorbunova SIRT6 promotes DNA repair under stress by activating PARP1 Science 332 2011 1443 1446
77. R.U. Kadam, V.M. Kiran, and N. Roy Comparative protein modeling and surface analysis of Leishmania sirtuin: a potential target for antileishmanial drug discovery Bioorg. Med. Chem. Lett. 16 2006 6013 6018
78. R.U. Kadam, J. Tavares, V.M. Kiran, A. Cordeiro, A. Ouaissi, and N. Roy Structure function analysis of Leishmania sirtuin: an ensemble of in silico and biochemical studies Chem. Biol. Drug Des. 71 2008 501 506
79. S. Kaur, A.V. Shivange, and N. Roy Structural analysis of trypanosomal sirtuin: an insight for selective drug design Mol. Divers. 14 2010 169 178
80. M.B.P. Soares, C.V. Silva, T.M. Bastos, E.T. Guimarães, C.P. Figueira, D. Smirlis, and W.F. Azevedo Jr. Anti-Trypanosoma cruzi activity of nicotinamide Acta Trop. 122 2012 224 229
81. C.I. Liu, G.Y. Liu, Y. Song, F. Yin, M.E. Hensler, W.Y. Jeng, V. Nizet, A.H. Wang, and E. Oldfield A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence Science 319 2008 1391 1394
82. D. Sereno, A.M. Alegre, R. Silvestre, B. Vergnes, and A. Ouaissi In vitro antileishmanial activity of nicotinamide Antimicrob. Agents Chemother. 49 2005 808 812
83. K. Maiese, Z.Z. Chong, J. Hou, and Y.C. Shang The vitamin nicotinamide: translating nutrition into clinical care Molecules 14 2009 3446 3485
84. B. Vergnes, L. Vanhille, A. Ouaissi, and D. Sereno Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase Acta Trop. 94 2005 107 115
85. J. Tavares, A. Ouaissi, A.M. Silva, P.K.T. Lin, N. Roy, and A. Cordeiro-da-Silva Anti-leishmanial activity of the bisnaphthalimidopropyl derivatives Parasitol. Int. 61 2012 360 363
86. J. Tavares, A. Ouaissi, P.K.T. Lin, I. Loureiro, S. Kaur, N. Roy, and A. Cordeiro-da-Silva Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1 ChemMedChem 5 2010 140 147
87. D. Prusty, P. Mehra, S. Srivastava, A.V. Shivange, A. Gupta, N. Roy, and S.K. Dhar Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth FEMS Microbiol. Lett. 282 2008 266 272
88. A. Mai, S. Massa, S. Lavu, R. Pezzi, S. Simeoni, R. Ragno, F.R. Mariotti, F. Chiani, G. Camilloni, and D.A. Sinclair Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (sirtuin) inhibitors J. Med. Chem. 48 2005 7789 7795
89. A.Y. Zhu, Y. Zhou, S. Khan, K.W. Deitsch, Q. Hao, and H. Lin Plasmodium falciparum Sir2A preferentially hydrolyzes medium and long chain fatty acyl lysine ACS Chem. Biol. 7 2012 155 159
90. C. Peng, Z. Lu, Z. Xie, Z. Cheng, Y. Chen, M. Tan, H. Luo, Y. Zhang, W. He, K. Yang, B.M. Zwaans, D. Tishkoff, L. Ho, D. Lombard, T.C. He, J. Dai, E. Verdin, Y. Ye, and Y. Zhao The first identification of lysine malonylation substrates and its regulatory enzyme Mol. Cell. Proteomics 10 2011 M111.012658
91. J. Du, Y. Zhou, X. Su, J.J. Yu, S. Khan, H. Jiang, J. Kim, J. Woo, J.H. Kim, B.H. Choi, B. He, W. Chen, S. Zhang, R.A. Cerione, J. Auwerx, Q. Hao, and H. Lin Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase Science 334 2011 806 809
92. +-dependent deacetylase Mol. Biochem. Parasitol. 158 2008 139 151
93. J.C. Milne, and J.M. Denu The Sirtuin family: therapeutic targets to treat diseases of aging Curr. Opin. Chem. Biol. 12 2008 11 17
94. W. Zheng, Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction, Mini Rev. Med. Chem, in press.
95. S.M. Rich, F.H. Leendertz, G. Xu, M. LeBreton, C.F. Djoko, M.N. Aminake, E.E. Takang, J.L. Diffo, B.L. Pike, B.M. Rosenthal, P. Formenty, C. Boesch, F.J. Ayala, and N.D. Wolfe The origin of malignant malaria Proc. Natl. Acad. Sci. U. S. A. 106 2009 14902 14907
96. R.T. Jacobs, and C. Ding Recent advances in drug discovery for neglected tropical diseases caused by infective kinetoplastid parasites Annu. Rep. Med. Chem. 45 2010 277 294
97. P.W. Gething, A.P. Patil, D.L. Smith, C.A. Guerra, I.R. Elyazar, G.L. Johnston, A.J. Tatem, and S.I. Hay A new world malaria map: Plasmodium falciparum endemicity in 2010 Malar. J. 10 2011 378
98. H. Noedl, Y. Se, K. Schaecher, B.L. Smith, D. Socheat, and M.M. Fukuda Evidence of artemisinin-resistant malaria in western Cambodia N. Engl. J. Med. 359 2008 2619 2620
99. A.M. Dondorp, F. Nosten, P. Yi, D. Das, A.P. Phyo, J. Tarning, K.M. Lwin, F. Ariey, W. Hanpithakpong, S.J. Lee, P. Ringwald, K. Silamut, M. Imwong, K. Chotivanich, P. Lim, T. Herdman, S.S. An, S. Yeung, P. Singhasivanon, N.P. Day, N. Lindegardh, D. Socheat, and N.J. White Artemisinin resistance in Plasmodium falciparum malaria N. Engl. J. Med. 361 2009 455 467
100. A.P. Phyo, S. Nkhoma, K. Stepniewska, E.A. Ashley, S. Nair, R. McGready, C. Ler Moo, S. Al-Saai, A.M. Dondorp, K.M. Lwin, P. Singhasivanon, N.P. Day, N.J. White, T.J. Anderson, and F. Nosten Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study Lancet 379 2012 1960 1966
101. V.I. Carrara, J. Zwang, E.A. Ashley, R.N. Price, K. Stepniewska, M. Barends, A. Brockman, T. Anderson, R. McGready, L. Phaiphun, S. Proux, M. van Vugt, R. Hutagalung, K.M. Lwin, A.P. Phyo, P. Preechapornkul, M. Imwong, S. Pukrittayakamee, P. Singhasivanon, N.J. White, and F. Nosten Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment PLoS One 4 2009 e4551
102. J.M. Villalba, and F.J. Alcaín Sirtuin activators and inhibitors Biofactors 38 2012 349 359
103. S.S. Mahajan, V. Leko, J.A. Simon, and A. Bedalov Sirtuin modulators Handb. Exp. Pharmacol. 206 2011 241 255
104. + dependent histone deacetylases (sirtuins) Curr. Pharm. Des. 14 2008 562 573
105. Y. Cen Sirtuins inhibitors: the approach to affinity and selectivity Biochim. Biophys. Acta 1804 2010 1635 1644
106. L. Chen Medicinal chemistry of sirtuin inhibitors Curr. Med. Chem. 18 2011 1936 1946
107. M.T. Borra, and J.M. Denu Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases Methods Enzymol. 376 2004 171 187
108. B.C. Smith, W.C. Hallows, and J.M. Denu Mechanisms and molecular probes of sirtuins Chem. Biol. 15 2008 1002 1013
109. B.D. Sanders, B. Jackson, and R. Marmorstein Structural basis for sirtuin function: what we know and what we don't Biochim. Biophys. Acta 1804 2010 1604 1616
110. Y. Zhou, H. Zhang, B. He, J. Du, H. Lin, R.A. Cerione, and Q. Hao The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5) J. Biol. Chem. 287 2012 28307 28314
111. B. He, J. Du, and H. Lin Thiosuccinyl peptides as Sirt5-specific inhibitors J. Am. Chem. Soc. 134 2012 1922 1925
112. A.A. Religa, and A.P. Waters Sirtuins of parasitic protozoa: in search of function(s) Mol. Biochem. Parasitol. 185 2012 71 88